150401-96-0

Basic information

• Product Name: 6-METHYL-BETA-OXO-2-PYRIDINEPROPANOIC ACID ETHYL ESTER
• Synonyms: 6-METHYL-BETA-OXO-2-PYRIDINEPROPANOIC ACID ETHYL ESTER;ethyl 3-(6-methylpyridin-2-yl)-3-oxopropanoate;3-(6-methyl-pyridin-2-yl)-3-oxo-propionic acid ethyl ester
• CAS NO: 150401-96-0
• Molecular Formula: C11H13NO3
• Molecular Weight: 207.228
• Mol File: 150401-96-0.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-METHYL-BETA-OXO-2-PYRIDINEPROPANOIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 6-METHYL-BETA-OXO-2-PYRIDINEPROPANOIC ACID ETHYL ESTER(150401-96-0)
• EPA Substance Registry System: 6-METHYL-BETA-OXO-2-PYRIDINEPROPANOIC ACID ETHYL ESTER(150401-96-0)

Safety Data

• Hazardous Substances Data: 150401-96-0(Hazardous Substances Data)

Upstream product

• 13602-11-4 6-methylpicolinic acid methyl ester 
• 141-78-6 ethyl acetate 
• 934-60-1 6-methyl-2-pyridinecarboxylic acid 
• 39640-51-2 ethyl 6-methylpyridine-2-carboxylate 

Relevant articles and documents

GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES

Conjugates comprising GalNAc moiety and a TGFβR1 inhibitor are provided. In some embodiments, the conjugates are useful for the treatment of viral infections, cancer, and fibrosis.

Growth Factor Receptor antagonists. Preparation method and application thereof

The invention relates to a small molecule antagonist for transforming growth factor β receptors, a method for preparing the small molecule antagonist, and application of the small molecule antagonist in preparation of drugs. The small molecule antagonist for transforming the growth factor β receptor has the application of treating and/or preventing various diseases mediated by ALK5, and has great clinical application potential.

SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF CANCERS, INCLUDING HEPATOCELLULAR CARCINOMA, AND AS INHIBITORS OF HEPATITIS VIRUS REPLICATION

Pharmaceutical compositions of the invention are presented which comprise substiuted aminothiazoles derivatives. The substiuted aminothiazoles derivatives have a disease-modifying action in the treatment of diseases associated with unregulated cell growth. Such diseases include cancers such as hepatocellular carcinoma, and viral infections from a hepatitis virus.